Word: colonics
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...raise fresh questions about the safety and efficacy of two dietary supplements. A six-week trial of ginkgo, touted to enhance memory, found no improvement in memory, learning or concentration among healthy people with no neurological symptoms, compared with a similar group taking placebo capsules. A separate study of colon-cancer patients revealed that St. John's wort, used to fight depression, interferes with the potentially beneficial effects of irinotecan, a widely prescribed chemotherapy drug...
DIED. C. JAMES CARRICO, 67, surgeon who as a young resident was first to treat President Kennedy in a Dallas emergency room on Nov. 22, 1963; of colon cancer; on Whidbey Island, Wash...
...plan was to follow the women for an average of eight years and record how many suffered from heart attacks, strokes, blood clots, hip fractures or colon cancer. From the outset, a safety board monitored the data to ensure that the study would be stopped before its scheduled ending in 2005 if there was evidence of such a clear benefit that it would be unethical to withhold the drug treatment from those women in the control group. It would also be stopped if, conversely, the risks of HRT so obviously outweighed the benefits that women in the treatment group should...
...COLON CANCER Colon-cancer rates in the WHI were lower in women taking HRT, but doctors don't feel that the protection against colon cancer outweighs the risk of breast cancer. Early detection of colon cancer is the best weapon against widespread disease; regular colon checkups are a good idea. Eating fruits and vegetables and exercising could also help...
Most cancer specialists, though, believe that while Erbitux and the science behind its development are radical, both are solid. Erbitux can home in on a protein beacon found on 80% of tumors, making it a promising candidate for treating a range of cancers, from breast to lung to colon. "Nobody has ever questioned the value or the trustworthiness of the science," says Dr. Larry Norton, head of solid tumor oncology at Memorial Sloan-Kettering Cancer Center in New York City...